Intended for healthcare professionals

Letters Screening for atrial fibrillation

Screening for atrial fibrillation: waiting for randomised trial data

BMJ 2019; 365 doi: (Published 04 June 2019) Cite this as: BMJ 2019;365:l2383
  1. Robert Steele, independent chair,
  2. John Marshall, evidence lead,
  3. Anne Mackie, director of screening
  1. UK National Screening Committee, London SE1 8UG, UK
  1. r.j.c.steele{at}

We agree with Berge that Wilson and Jungner would not approve of screening for atrial fibrillation.1 The key problems are that we do not know whether screen detected atrial fibrillation carries the same risk of stroke as disease that is clinically detected …

View Full Text

Log in

Log in through your institution


* For online subscription